USPTO serial 78939689
Serial No. 78939689
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- LEVINE, HOWARD B
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with Serial No. 78939689?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
NEW BRUNSWICK, NJ
NEW BRUNSWICK, NJ
Morris Plains, NJ
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jake Feldman
Jake Feldman Johnson & Johnson Law DepartmentOne Johnson & Johnson PlazaNew Brunswick, NJ 08933-7001UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Non-medicated mouth rinses and non-medicated breath fresheners; mouthwash; non-medicated oral dissolving breath freshener strips; effervescent denture cleanser; toothpaste; skin soap; hand and body lotion; skin cream; hand cream; cold cream; all purpose cotton swabs for personal use; lip balm | ACTIVE | — |
| 005 | Therapeutic ophthalmic preparations; eye drops; laxatives; antacids for the treatment of gastrointestinal disorders; antacid mints; antidiarrheal preparations; pharmaceutical preparations for the treatment of diarrhea, constipation, and abdominal discomfort; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical preparations for human use being gastric fluid inhibitors; pharmaceutical preparations, namely, a histamine H2-receptor antagonist for the treatment of upper respiratory conditions; pharmaceutical preparation for the alleviation of ulcers, treatment and/or alleviation of heartburn and other gastro-intestinal disorders; medicated mouth rinses and breath fresheners; antiseptic mouthwash; denture adhesive cream; antiseptic throat lozenges; antiseptic for personal hygiene; anti-plaque mouth rinse; dental plaque remover; preparation for relief of anorectal discomfort; ointment for the treatment of minor rectal inflammation and minor skin irritations; hydrocortisone ointment; hemorrhoidal suppository; hemorrhoid relief preparation; medicated personal cleansers; medically treated hemorrhoidal pads, ointment and witch hazel cream; athlete's foot preparation; anti-fungal preparation for medical use; medicated skin lotion; anti-itch preparation; medicated hand lotion; topical analgesic preparations; medical compound in the form of ointments and creams for treatment of wounds, skin abrasions, bruises, chapped skin, bedsores, sore feet, burns, scalds, sunburns, wind bite, diaper rash and rectal irritation for use in dermatology and pediatrics; mixture of antibiotics for use in the treatment of general and local bacterial and virus infections; pharmaceutical preparations for treating dermatosis; medicated skin lotion for the relief of itch caused by insect bites, eczema, sunburn and poison ivy; mixture of antibiotics for use in the treatment of general and local bacterial and virus infections; medicated lip balm for treatment of cold sores and dry or chapped lips; pharmaceutical preparation, namely, a topical dermatological for treatment of alopecia; vitamins; adhesive bandages; pharmaceutical preparation for temporary relief of nasal congestion; sinus and allergy preparations containing antihistamines, analgesics and decongestant; pharmaceutical preparations containing diphenhydramine hydrochloride for the relief of hay fever symptoms, itching skin, hives, motion sickness, cough, and sleeping difficulty; medicinal pharmaceutical preparations, namely, allergy prevention cromolyn sodium based allergy prevention nasal spray; cough syrup; sleep aid preparation, namely, sleeping pills; allergy prevention nasal spray; pharmaceutical preparations for the relief of symptoms affecting any part of the respiratory tract; pharmaceutical preparations for the relief and prevention of upper respiratory and sinus symptoms and infections; sinus headache tablets; sinus medication; pharmaceutical preparations for use in connection with upper respiratory conditions; medicinal preparation intended for use as a sympathomimetic cough medication, decongestant and antihistamine; allergy and sinus medications; air freshener; refills for air fresheners; analgesic/antispasmodic for relief of menstrual discomfort; pain relieving adhesive skin patches; sleep aids for the treatment of insomnia; cough and throat drops; analgesics; anti-inflammatory pharmaceutical preparations; analgesic preparations for the treatment of headaches, backaches, back pain, menstrual pain, and muscle pain; pharmaceutical preparations for the treatment of urological conditions and overactive bladder; dimenhydrinate tablets useful in the prevention and treatment of motion sickness, nausea and vomiting; histamine antagonist; liquid fiber composition for the treatment of gastro-intestinal disorders; pharmaceutical substances, namely, miconazole nitrate antimicrobial cream; anti-allergic solution for the prevention and treatment of allergic rhinitis; pediatric cold preparations; allergy relief medication | ACTIVE | — |
| 016 | Facial tissues | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by JOHNSON & JOHNSON
- Other trademarks owned by JOHNSON & JOHNSON
- Other trademarks owned by Warner-Lambert Company LLC
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 016
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 5, 2009 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 5, 2009 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 29, 2008 | EX1G | SOU EXTENSION 1 GRANTED | — |
| May 27, 2008 | EXT1 | SOU EXTENSION 1 FILED | — |
| May 27, 2008 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 16, 2008 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 16, 2008 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 4, 2007 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 11, 2007 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 22, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| Aug 3, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 25, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 18, 2007 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Jun 18, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 18, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 18, 2007 | ALIE | ASSIGNED TO LIE | — |
| Jun 1, 2007 | PAPER RECEIVED | — | |
| May 17, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 17, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 29, 2007 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 12, 2007 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 7, 2007 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Nov 20, 2006 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 20, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 11, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 3, 2006 | MDSC | NOTICE OF DESIGN SEARCH CODE MAILED | — |
| Aug 2, 2006 | NWAP | NEW APPLICATION ENTERED | — |